Podcasts about swiss association

Reading poetry can reduce stress and help give you words to express the things you're feeling. And reading a poem out loud has been shown to be a surprisingly simple way to activate your relaxation response and bring about a sense of calm. It's all to do with the way it slows and controls your breathing rate, which in turn stimulates your parasympathetic nervous system and can lead to many beneficial effects. Michael Mosley speaks to Dietrich von Bonin from the Swiss Association of Art Therapies, who says as little as 5 minutes of rhythmic poetry read aloud can be even more effective than slow-paced breathing at relaxing your body and mind. Our volunteer Colm dives into the world of Irish poetry and incorporates reading it aloud into his bedtime routine.Series Producer: Nija Dalal-Small Editor: Zoë Heron A BBC Studios production for BBC Sounds / BBC Radio 4.

It was a verdict that caused a stir worldwide and overnight, the Swiss Association of Climate Seniors became world-famous. The more than 2500 members had sued the country before the European Court of Human Rights claiming the human rights of older women had been violated and Switzerland would not do enough against global warming. The court saw this confirmed and now the country must react politically. Board member Pia Hollenstein believes that the verdict could set a precedent for further lawsuits worldwide. - Es war ein Urteil, das weltweit für Aufsehen sorgte und über Nacht wurde der Schweizer Verein der Klimaseniorinnen weltbekannt. Die über 2500 Mitglieder hatten das Land am Europäischen Gerichtshof für Menschenrechte verklagt, weil die Menschenrechte älterer Frauen verletzt wurden und die Schweiz nicht genug gegen die fortschreitende Klimaerwärmung tun würde. Das Gericht sah dies bestätigt und nun muss das Land politisch reagieren. Das Urteil könnte zum Präzedenzfall für weitere Klagen weltweit werden, glaubt auch Vorstandsmitglied Pia Hollenstein.

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patricia Gill, the founder of SAMHI, the Swiss Association for Mental Health Innovation, which is supporting AI and tech solutions for mental health, with a main goal of bringing relevant deep tech, mental health solutions to the market.   They discuss how tech and AI are advancing mental health innovation and how mental health services around the world are facing significant challenges from increasing demand, the need to tackle inequalities, lack of integration with other health care provision, and persistent funding inequity.   In this episode you will learn: How the Swiss Association for Mental Health Innovation works Tools to help people with mental health Collaboration with the pharmaceutical industry Pharma's role in fighting the mental health crisis   Click to connect with Dr. Andree Bates for more information in this episode: https://eularis.com/ For more information about SAMHI head to https://www.samhi.org/   AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses  her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.   Resources: Dr. Andree Bates LinkedIn | Facebook | Twitter

Kennst du noch Kitt, das sprechende Auto aus Knight Rider? Kitt konnte sich nicht nur mit seinem Fahrer Michael unterhalten. Er konnte auch völlig autonom fahren und gefährliche Manöver ausführen. Nach seinem Vorbild sind autonome Fahrzeuge ab 1982 in den Fokus der Science-Fiction geraten, nicht selten auch mit einem bitteren Beigeschmack über die computergesteuerte Zukunft, in der Roboter über die Menschheit herrschen. Während autonomes Fahren in den 80er Jahren tatsächlich noch komplette Zukunftsmusik war, stellen wir uns heute nur noch die Frage, wann es denn nun endlich so weit ist. In Deutschland gibt es bereits beschlossene Gesetze und Gesetzesentwürfe für verschiedene Stufen des autonomen Fahrens, in den USA gehören selbstfahrende Taxen in diversen Städten schon zum Stadtbild. Und in der Schweiz? Ein Unternehmen, dass sich in der Schweiz äusserst genau mit der Zukunft des Autonomous Driving auseinandersetzt, ist die SBB. Als öffentliches Transportunternehmen bleibt ihnen auch gar nichts anderes übrig. Dass autonom fahrende Fahrzeuge die Zukunft sind, ist laut Carolin Holland, Leiterin des Competence Centers Autonomous Driving der Schweizerischen Bundesbahnen, nämlich schon längst klar. Ihrer Meinung nach wird das autonome Fahren einen riesigen Einfluss auf unsere Mobilität haben. Ein mögliches Szenario, welches gemäss Carolin in der Schweiz wirklich noch in ferner Zukunft liegt, sind beispielsweise selbstfahrende Fahrzeuge, die Menschen mit einer eingeschränkten Mobilität transportieren. Bis dahin in es noch ein weiter weg. Damit diese Art der Mobilität aber vorangetrieben wird, wurde in der Schweiz die SAAM gegründet, die Swiss Association for Autonomous Mobility. Über dreissig Schweizer Unternehmen sind bereits Mitglied. Carolin selbst beschäftigt sich innerhalb der SAAM mit der sozialen Akzeptanz von autonom fahrenden Fahrzeugen. In dieser Folge des InnoPodcasts geht es vor allem um die Fragen, wie ein Transportunternehmen wie die SBB mit den rasanten Entwicklungen im Bereich Autonomous Driving umgeht und ordnet die bisherigen Erkenntnisse in einen globalen Kontext ein. Sie erklärt, welche Levels des autonomen Fahrens es gibt und auf welches Level die Schweiz derzeit in verschiedenen Projekten hinarbeitet. Auch die unterschiedlichen Technologien, die bereits getestet oder in anderen Ländern eingesetzt werden, greift sie im Gespräch mit Khalil auf. Und gegen Ende der Folge nimmt sie uns allen noch die Angst vor den Schreckensszenarien aus den Sciencefiction Filmen. Aber dafür musst du die Folge schon hören. ;-) Carolin Holland hat an der Technischen Universität München Maschinenbau studiert und als Diplom Ingenieurin abgeschlossen. Nach einer kurzen Phase als wissenschaftliche Mitarbeiterin an der Uni ist sie als Entwicklungsingenieurin zur BMW Group gegangen. Darauf folgte noch ein Halt bei AUDI als Ingenieurin für Eigenschaftsentwicklung. Seit 2016 war sie in verschiedenen Funktionen bei der SBB beschäftigt und leitet seit Mai 2021 das Kompetenzzentrum für autonomes Fahren. Und: Diese Episode ist Khalils letzte Episode als Host des InnoPodcast. Der InnoPodcast wird neu konzipiert und sehr bald im neuen Gewand weitergeführt. Bleibt gespannt und abonniert den InnoPodcast, um den Neustart nicht zu verpassen. Nach vier Jahren übernimmt Khalil neue Aufgaben innerhalb der Post. Im Bereich Information/Technologie baut er mit den Bereich Digital bzw. Innovation Enabling auf. In dem Rahmen arbeitet er am Bau und Launch von Minimal Viable Products und der Digitalisierung der Post. Ihr erreicht ihn weiterhin via LinkedIn und vielleicht auch als Gast in einer Episode

Charlie Fisher is a co-founder and director of the Co-operative Architecture Practice, Transition by Design. He's a researcher and urban-instigator working on regenerative land use approaches and more collaborative forms of city-making driven by the belief that to unlock collective imagination for equitable societies we must remove structural barriers that are preventing people from connecting with one another.His role over the past decade has been to build capacities within land-based organisations, primarily around urban affordable housing and mechanisms for holding land in the commons. He writes about, and runs workshops on, group dynamics, decision-making, housing finance, incorporation approaches, legal structures, stakeholder mapping, business planning, and visioning. In 2020, he was developing the Oxygen Fund, a £5m revolving equity fund with the Oxfordshire Growth Deal, which led him to explore how regenerative land use can be supported through Distributed Co-operative Organisations (DisCOs

Automated vehicles are a global phenomenon, with global impacts and global challenges. Around the world, countries are contemplating how to introduce AVs into the transportation system in a way that ensures the technology creates change for the better, and they're taking different approaches to AV regulation, testing and deployment, and integrating the technology into public transit systems.In a new series, “AVs Around the World,” PAVE will spotlight different countries and talk to stakeholders about how they're approaching the AV future.  How is this technology regulated? What forms of AV technology are deployed? What has public reception been?In our first episode of “AVs Around the World,” we look at AVs in Switzerland, where they have actively sought to integrate AV technology into their robust public transit system. We will talk to Oliver Nahon from the Swiss Association for Autonomous Mobility and Stafano Lungo, the Head of Automated Driving at Embotech, about how AVs are transforming the Swiss transportation system.Panelists:Oliver Nahon – Strategic Manager, Swiss Association for Autonomous MobilityStefano Lungo – Head of Automated Driving, Embotech

Jamie Vrijhof-Droese is a cross-border wealth management expert, public speaker, and writer. She heads the business development of WHVP and advises a group of international clients with respect to international diversification and asset protection. She is a board member of the Swiss Association of Wealth Managers, the central agency for independent wealth managers in Switzerland. Jamie started her banking career back in 2009 at Credit Suisse, where she worked in different departments, amongst others in Credit Risk Management, Consumer Finance, and Private Banking. Her experience is topped off with several years of working experience as a Financial Planner specialized in providing tailor-made international insurance and investment solutions. Last but not least she worked as a Project Manager for a boutique consulting firm, as well as a cross-industry association designed to strengthen Switzerland's start-up ecosystem. Jamie co-authored the book “Swiss Money Secrets” (Banyan Hill Publishing, 2018) and holds a Bachelor's degree in Banking and Finance as well as a Master of Business Administration (MBA) from the University of St. Gallen. This episode talks about: Jamie's background in wealth management and banking in Switzerland. Potential international solutions for US investors Typical funding requirements when it comes to Swiss banking What to consider before investing in Switzerland or other offshore places? The importance of relationship building and trust in wealth management Asset protection using Swiss banking products/methods? A brief overview on the taxation of international accounts for US investors Typical fees when it comes to investing in a Swiss account Could you borrow against your Swiss Bank funds by leveraging it as collateral? What are the typical rates of return on a Swiss investment (example of one type of investment) account? Can you use a self-directed IRA to own a Swiss account? Do we convert US dollars into other currencies when investing offshore? If so, what are the advantages of doing so? How does one measure the strength of the US dollar? Do you have to physically go to Switzerland to open a Swiss bank account? To connect with Jamie Vrijhof-Droese, please visit:

Claudia speaks to Saskia Stucki, who sees overlaps between International Humanitarian Law and Animal Welfare Law as providing fertile ground for legal conceptual development. Saskia Stucki believes ‘Animal Warfare Law' offers a way forward for considering how animal welfare and animal rights could better complement one another. Date recorded: 6 May 2020Guest: Saskia Stucki is Senior Research Fellow at the Max Planck Institute for Comparative Public Law and International Law in Heidelberg, Germany. In 2018/2019, she was a visiting researcher at the Harvard Law School Animal Law & Policy Program, where she worked on her two-year postdoctoral research project “Trilogy on a Legal Theory of Animal Rights” (funded by the Swiss National Science Foundation). She studied law at the University of Basel, Switzerland, where she also obtained her doctoral degree in 2015. The resulting book on “Fundamental Rights for Animals” (2016) won four awards, among other the biennial award of the Swiss Association for the Philosophy of Law and Social Philosophy. Her research interests include animal law and ethics, animal personhood and rights, legal animal studies and comparative animal welfare law, legal theory, human rights philosophy, international humanitarian law, and environmental law. You can find out more about Saskia and her work here. Host: Claudia Hirtenfelder is a PhD Candidate in Geography and Planning at Queen's University and is currently undertaking her own research project that looks at the historical relationships between animals and cities. Contact Claudia via email (17ch38@queensu.ca) or follow her on Twitter (@ClaudiaFTowne).Featured readings:  The Humanization of Humanitarian Law by Theodor Meron; The War Against Animals by Dinesh Wadiwel; and Beyond Animal Welfare/Warfare Law: Humanizing the war on animals and the need for complementary animal rights by Saskia Stucki (forthcoming)Bed Music created by Gordon Clarke (Instagram: @_con_sol_)Podcast Logo created by Jeremy John (Website)Sponsored by Animals in Philosophy, Politics, Law and Ethics – A.P.P.L.E (Website) Part of iROAR, an Animals Podcasting Network and the CFRC Podcast Network

Listen in to Amina's conversation with Dr. Andreas Krafft as they discuss the power of hope, one of the constructs studied in the second round of IIIT's research for the Mapping the Terrain Study, part of its Advancing Education in Muslim Societies (AEMS) initiative. For the past ten years, Dr. Krafft has been working on a very exciting project called the Hope-Barometer, which is an annual survey of people's hopes and expectations for the future. This has included approximately 10,000 people in 14 different countries each year. Dr. Krafft reveals to Amina what inspired this initiative and what the most important findings have been. They also discuss the benefits of hope, its various sources, as well as its relationship to spirituality and religion. Dr. Andreas M. Krafft is a Research Associate and Lecturer at the Institute of Systemic Management and Public Governance, University of St. Gallen (Switzerland). He is also the head of the International Hope-Barometer Research Network and Co-President of swissfuture, the Swiss Society for Future Studies. Dr. Krafft is also a Board member of SWIPPA, the Swiss Association of Positive Psychology.

Listen in to Amina's conversation with Dr. Andreas Krafft as they discuss the power of hope, one of the constructs studied in the second round of IIIT's research for the Mapping the Terrain Study, part of its Advancing Education in Muslim Societies (AEMS) initiative. For the past ten years, Dr. Krafft has been working on a very exciting project called the Hope-Barometer, which is an annual survey of people's hopes and expectations for the future. This has included approximately 10,000 people in 14 different countries each year. Dr. Krafft reveals to Amina what inspired this initiative and what the most important findings have been. They also discuss the benefits of hope, its various sources, as well as its relationship to spirituality and religion. Dr. Andreas M. Krafft is a Research Associate and Lecturer at the Institute of Systemic Management and Public Governance, University of St. Gallen (Switzerland). He is also the head of the International Hope-Barometer Research Network and Co-President of swissfuture, the Swiss Society for Future Studies. Dr. Krafft is also a Board member of SWIPPA, the Swiss Association of Positive Psychology.

Alors que la Swiss Football League sʹinterroge sur son avenir et sur une possible reprise du championnat au mois de juin, les joueurs se sentent oubliés. Ils aimeraient être mieux informés de la situation et être entendus également. Entretien avec Lucien Valloni, le président et fondateur de la SAFP, la Swiss Association of Football Players.

Moss can be a divisive subject among gardeners, but Erica Nordstrom's new book, titled "Moss - Discover. Gather. Grow. From forest to garden: a guide to the hidden world of moss" might help to persuade some of the non-believers. The book manages to combine botanical detail, a visit to some astonishing moss gardens in Japan, the US and the UK and some practical projects for making your own moss gardens. Here in Switzerland, the two webpages that will get you started are www.bryolich.ch for information on the Swiss Association of Bryology and Lichenology and www.bryophytes.ch for identification pictures and help on collecting samples and which mosses are protected and shouldn't be touched

“La réalité financière de l’IA? 3% du budget investi dans l’ensemble des activités IT de Suisse." Jérôme Berthier, Empowerment Foundation Celles et ceux qui ont suivi Airccelerate en 2018 ont entendu - et même vu - que l’intelligence artificielle (IA) a occupé nos podcasts et nos journées, avec la participation à plusieurs événements autour du big data en Suisse. Armés de micros, de jetons et d’une borne d’arcade (!) nous avons interrogés des professionnels intéressés par l’IA afin de mieux cerner les besoins actuels et les solutions existantes. Dans ce 26e épisode, WarcoBrienza et JeremieWagner reçoivent plusieurs experts publiés dans la récente étude pAIrspective: Jérôme Berthier (Empowerment Foundation), Paul Wang (Advisory Board Member chez High-Tech Bridge, Mt-Pelerin et membre de la direction pour Icon.ngo), Sandro Saitta (Chief Industry Advisor chez Swiss Data Science Center) ainsi que l’instigateur du projet, Lionel Clavien (CTO d’InnoBoost). L’utilisation de l’Intelligence Artificielle devient réalité, même en Suisse. Les professionnels de la finance, de la production, du marketing, des ventes ou des RH sont ou seront impactés dans leur quotidien, à des degrés variables. Pas évident pour autant de comprendre comment l’IA nous impacte(ra) à nos places de travail. Fin 2018, 115 personnes actives en Suisse se sont prêtées au jeu du questionnaire pAIrspective, étude dont l’objectif est de publier l’”état des besoins” actuels et des solutions qui s’y prêtent déjà. Quatre experts en IA nous accompagnent pour cette émission très spéciale: Jérôme Berthier travaille comme vice-président de l'Empowerment Foundation; il a préalablement dirigé l’une des plus importantes société IT de Suisse, ainsi qu’un Innovation Lab; Paul Wang est advisor stratégique en matière de cybersécurité et de gestion des risques. Membre de l'advisory board de Mt-Pelerin (projet blockchain dans la création de la banque du futur, combinant crypto-économie et finance traditionnelle) et de High-Tech Bridge (société spécialisée dans la détection des failles cybersécurité utilisant l'intelligence artificielle), il est aussi membre de la direction de Icon.ngo ( organisation non gouvernementale qui fédère une communauté européenne travaillant sur la confiance dans le cyberespace); Sandro Saitta a 10 ans d’expérience dans l’application de la Data Science dans des industries telles que la finance, les télécommunications, la chimie, les voyages en ligne et la vente au détail. Il est actuellement Chief Industry Advisor au Swiss Data Science Center. Sandro est titulaire d’un doctorat en informatique de l’EPFL et a fondé la Swiss Association for Analytics pour promouvoir la Data Science en Suisse; Lionel Clavien est l’auteur d’une thèse sur les robots mobiles autonomes, l’initiateur du livre blanc “L’Intelligence Artificielle en Suisse et en 2019” ainsi que le CTO d’InnoBoost, dont le coeur de métier est l’intégration de “briques d’IA” dans les infrastructures IT de sociétés cherchant à valoriser les données qu’elles traitent. Retrouvez les notes complètes de l'émission, ainsi que tous nos podcasts sur www.airccelerate.com Photo by https://www.empowerment.foundation

Why You Should Listen: In this episode, you will learn about EliSpot testing and the various testing options available through ArminLabs in Germany. About My Guest: My guest for this episode is Dr. Armin Schwarzbach. Armin Schwarzbach, MD, PhD is a medical doctor and a specialist in laboratory medicine from the laboratory ArminLabs in Augsburg, Germany. Dr. Schwarzbach began by studying biochemistry at Hoechst AG in Frankfurt, Germany and pharmacy at the University of Mainz in Germany in 1984. In 1985 he studied medicine for 6 years at the University of Mainz and finished his MD in 1991. Dr. Schwarzbach developed the worldwide first Radioimmunoassay (RIA) for human Gastric Inhibitory Polypeptide from 1986 – 1991, getting his PhD in 1992. He is member of the Swiss Association for tick-borne diseases, the German Association of Clinical Chemistry and Laboratory Medicine, and the German Society for Medical Laboratory Specialists. He is an Advisory Board member of AONM London, England, and Board member of German Borreliosis Society, and Member and former Board Member of the International Lyme and Associated Diseases Society (ILADS) and has served as an expert on advisory committees on Lyme Disease in England, Australia, Canada, Ireland, France, and Germany. Dr. Schwarzbach is the founder and CEO of ArminLabs in Augsburg, Germany and has specialized in diagnostic tests and treatment options for patients with tick-borne diseases for over 20 years. Key Takeaways: - What is an EliSpot? - What organisms can be tested for using EliSpot technology? - How specific is the EliSpot in testing for Borrelia, Bartonella, Babesia, and other organisms? - Does the state of the immune system matter when considering EliSpot results? - Which infections are the most persistent? - Can the EliSpot be used to track progress or success of treatment? - What is Yersinia and where might it be encountered? - Can EliSpot testing be used in newborns and infants? - What role do viruses such as EBV, CMV, Coxsackie, and others play in chronic illness? - Can Mast Cell Activation Syndrome be triggered by viruses? - Why are Mycoplasma and Chlamydia so important to explore? - Why is IgA testing a promising new direction in laboratory medicine? - Is CD57 helpful clinically? - What microbes are more commonly associated with specific medical conditions? - How common are Rickettsial organisms? - What is "Post Lyme Syndrome"? Is it real? Connect With My Guest: http://arminlabs.com Interview Date: February 27, 2019 Additional Information: To learn more, visit http://BetterHealthGuy.com. Disclaimer: The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority.